Reducing Clostridium difficile in the Inpatient Setting: A Systematic Review of the Adherence to and Effectiveness of C. difficile Prevention Bundles

Infection Control and Hospital Epidemiology

Volumn 38, Issue 6, 2017, Pages 639-650

  Barker, Anna K ^a   Ngam, Caitlyn ^a   Musuuza, Jackson S ^b   Vaughn, Valerie M ^c,d   Safdar, Nasia ^a,b,e,f  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e University of Wisconsin Health   (United States)

^f UWMF Centennial Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PROTON PUMP INHIBITOR;

ANTIBIOTIC THERAPY; CARE BUNDLE; CLEANING; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; HAND WASHING; HOSPITAL EQUIPMENT; HOSPITAL INFECTION; HUMAN; INFECTION PREVENTION; PATIENT EDUCATION; PATIENT ISOLATION; PROTOCOL COMPLIANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STAFF TRAINING; SYSTEMATIC REVIEW; UNIVERSAL PRECAUTION; WORKFLOW; ANTIMICROBIAL STEWARDSHIP; DISINFECTION; DISPOSABLE EQUIPMENT; EDUCATION; HOSPITAL PERSONNEL; HOSPITAL SERVICE; PEPTOCLOSTRIDIUM DIFFICILE; PROCEDURES; PROTECTIVE GLOVE; PSEUDOMEMBRANOUS COLITIS;

ANTIMICROBIAL STEWARDSHIP; CLOSTRIDIUM DIFFICILE; DISINFECTION; DISPOSABLE EQUIPMENT; ENTEROCOLITIS, PSEUDOMEMBRANOUS; GLOVES, PROTECTIVE; GUIDELINE ADHERENCE; HAND HYGIENE; HOUSEKEEPING, HOSPITAL; HUMANS; PATIENT CARE BUNDLES; PATIENT EDUCATION AS TOPIC; PATIENT ISOLATION; PERSONNEL, HOSPITAL;

EID: 85020535239     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2017.7     Document Type: Review

References (61)

1. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium difficile-related Mortality Rates, United States, 1999-2004. Emerg Infect Dis 2007;13:417-419.
2. Kuijper EJ, van Dissel JT, Wilcox MH. Clostridium difficile: changing epidemiology and new treatment options. Curr Opin Infect Dis 2007;20:376-383.
3. Freeman J BM, Baines SD, Corver J, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010;23:529-549.
4. Deneve C, Janoir C, Poilane I, Fantinato C, Collignon A. New trends in Clostridium difficile virulence and pathogenesis. Int J Antimicrob Agents 2009;33:S24-S28.
5. Lessa FC, Yi M, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015;372: 825-834.
6. Gabriel L, Beriot-Mathiot A. Hospitalization stay and costs attributable to Clostridium difficile infection a critical review. J Hosp Infect 2014;88:12-21.
7. Inclusion criteria for reporting C. difficile infection to the surveillance system. Health Protection Agency of the United Kingdom website. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/328334/c-difficile-inclusion-criteria-for-reporting.pdf. Published 2014. Accessed April 4, 2016.
8. Antibiotic Resistance Threats in the United States. Centers for Disease Control and Prevention website. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf. Published 2013. Accessed November 12, 2015.
9. CMS to improve quality of care during hospital inpatient stays. Centers for Medicare & Medicaid Services website. https://www.cms.gov/newsroom/mediareleasedatabase/fact-sheets/2014-factsheets-items/2014-08-04-2.html. Published 2014. Accessed April 2, 2016.
10. Hedge DD, Strain JD, Heins JR, Farver DK. New advances in the treatment of Clostridium difficile infection (CDI). Ther Clin Risk Manag 2008;4:949-964.
11. Eyre DW, Cule ML, Wilson DJ, et al. Diverse sources of C. difficile infection identified on whole-genome sequencing. NEJM 2013;369:1195-1205.
12. Walker AS, Eyre D, Wyllie DH, et al. Characterization of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and moleculat typing. PLOS Med. 2012;9:e1001172.
13. Kramer A SI, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis 2006;6:30.
14. Kundrapu S, Venkata S, Jury I, Deshpande A, Donskey CJ. A randomized trial of soap and water hand wash versus alcohol hand rub for removal of Clostridium difficile spores from hands of patients. Infect Control Hosp Epidemiol 2014;35:204-206.
15. Jernigan JA, Siegman-Igra Y, Guerrant RC, Farr BM. A randomized crossover study of disposable thermometers for prevention of Clostridium difficile and other nosocomial infections. Infect Control Hosp Epdemiol 1998;19:494-499.
16. Noto MJ, Domenico HJ, Byrne DW, et al. Chlorhexidine bathing and health care-associated infections. JAMA 2015;313:369-378.
17. Kundraphu S, Sunkelsula V, Jury LA, Sitzlar BM, Donskey CJ. Daily disinfection of high-touch surfaces in isolation rooms to reduce contamination of healthcare workers' hands. Infect Control Hosp Epidemiol 2012;33:1039-1042.
18. Barbut F, Menuet D, Verachten M, Girou E. Comparison of the efficacy of a hydrogen peroxide dry-mist disinfection system and sodium hypochlorite solution for eradication of Clostridium difficile spores. Infect Control Hosp Epidemiol 2009;30:507-514.
19. Furuya EY, Dick A, Perencevich EN, Pogorzelska M, Goldmann D, Stone PW. Central line bundle implementation in US intensive care units and impact on bloodstream infections. PLoS One 2011;6: e15452.
20. Moher D, Liberati A, Tetzlaff J, Altman DG, the PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-269.
21. Dane AV, Schneider B. Program integrity in primary and early secondary prevention: are implementation effects out of control? Clin Psychol Rev 1998;18:23-45.
22. Hoffmann T, Glasziou PP, Boutron I, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ 2014;348:g1687.
23. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Commun Health 1998;52:377-384.
24. O'Connor SR, Tully MA, Ryan B, Bradley JM, Baxter GD, McDonough SM. Failure of numerical quality assessment scale to identify potential risk of bias in a systematic review: a comparison study. BMC Res Notes 2015;8:224.
25. Gulihar A, Nixon M, Jenkins D, Taylor GJ. Clostridium difficile in hip fracture patients: prevention, treatment and associated mortality. Injury 2009;40:746-751.
26. Marufu O, Desai N, Aldred D, Brown T, Eltringham I. Analysis of interventions to reduce the incidence of Clostridium difficile infection at a London teaching hospital trust, 2003-2011. J Hosp Infect 2015;89:38-45.
27. Mattner F, Winterfeld I, Oswald B, Solbach W. Successful bundle of prevention measures against a high CDAD incidence at a university hospital. Hyg Med 2008;33:346-352.
28. Oleastro M, Coelho M, Giao M, et al. Outbreak of Clostridium difficile PCR ribotype 027-the recent experience of a regional hospital. BMC Infect Dis 2014;14:209.
29. Power M, Wigglesworth N, Donaldson E, Chadwick P, Gillibrand S, Goldmann D. Reducing Clostridium difficile infection in acute care by using an improvement collaborative. BMJ 2010; 341:c3359.
30. Price J, Cheek E, Lippett S, et al. Impact of an intervention to control Clostridium difficile infection on hospital- and community-onset disease; an interrupted time series analysis. Clin Microbiol Infect 2010;16:1297-1302.
31. Stone SP, Beric V, Quick A, Balestrini AA, Kibbler CC. The effect of an enhanced infection-control policy on the incidence of Clostridium difficile infection and methicillin-resistant Staphyloccocus aureus colonization in acute elderly medical patients. Age Ageing 1998;27:561-568.
32. Struelens MJ, Maas A, Nonhoff C, et al. Control of nosocomial transmission of Clostridium difficile based on sporadic case surveillance. Am J Med 1991;91:138S-144S.
33. White H, Wiselka M, Bell D. A multi-faceted approach of one teaching hospital NHS trust during the Clostridium difficile epidemic-antibiotic management and beyond. Antibiotics Basel 2016;5:E13.
34. Cheng VC, Chau P, So SY, et al. Containment of Clostridium difficile infection without reduction in antimicrobial use in Hong Kong. Eur J Clin Microbiol Infect Dis 2015;34:1381-1386.
35. Suzuki H, Senda J, Yamashita K, et al. Impact of intensive infection control team activities on the acquisition of methicillinresistant Staphylococcus aureus, drug-resistant Pseudomonas aeruginosa and the incidence of Clostridium difficile-associated disease. J Infect Chemother 2013;19:1047-1052.
36. You E, Song H, Cho J, Lee J. Reduction in the incidence of hospital-acquired Clostridium difficile infection through infection control interventions other than the restriction of antimicrobial use. Int J Infect Dis 2014;22:9-10.
37. Valiquette L, Cossette B, Garant MP, Diab H, Pepin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis 2007;45: S112-S121.
38. Muto CA, Blank M, Marsh JW, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis 2007;45:1266-1273.
39. Weiss K, Boisvet A, Chagnon M, et al. Multipronged intervention strategy to control an outbreak of Clostridium difficile infection (CDI) and its impact on the rates of CDI from 2002 to 2007. Infect Control Hosp Epidemiol 2009;30:156-162.
40. Abbett SK, Yokoe D, Lipsitz SR, et al. Proposed checklist of hospital interventions to decrease the incidence of healthcareassociated Clostridium difficile infection. Infect Control Hosp Epidemiol 2009;30:1062-1069.
41. Hanna H, Raad I, Gonzalez V, et al. Control of nosocomial Clostridium difficile transmission in bone marrow transplant patients. Infect Control Hosp Epidemiol 2000;21:226-228.
42. Whitaker J, Brown B, Vidal S, Calcaterra M. Designing a protocol that eliminates Clostridium difficile: a collaborative venture. Am J Infect Control 2007;35:310-314.
43. Wong-McClure RA, Ramirez-Salas E, Mora-Brenes N, et al. Long-term effect of infection control practices and associated factors during a major Clostridium difficile outbreak in Costa Rica. J Infect Dev Ctries 2013;7:914-921.
44. Mermel LA, Jefferson J, Blanchard K, et al. Reducing Clostridium difficile incidence, colectomies, and mortality in the hospital setting: a successful multidisciplinary approach. Jt Comm J Qual Patient Saf 2013;39:298-305.
45. Zafar AB, Gaydos LA, Furlong WB, Nguyen MH, Mennonna PA. Effectiveness of infection control program in controlling nosocomial Clostridium difficile. Am J Infect Control 1998;26:588-593.
46. Salgado CD, Mauldin PD, Fogle PJ, Bosso JA. Analysis of an outbreak of Clostridium difficile infection controlled with enhanced infection control measures. Am J Infect Control 2009; 37:458-464.
47. Lai KK, Melvin ZS, Menard MJ, Kotilainen HR, Baker S. Clostridium difficile-associated diarrheal epidemiology, risk factors, and infection control. Infect Control Hosp Epidemiol 1997;18:628-632.
48. Apisarnthanarak A, Zack JE, Mayfield JL, et al. Effectiveness of environmental nad infection control programs to reduce transmission of Clostridium difficile. Clin Infect Dis 2004;39:601-602.
49. Bishop J, Parry MF, Hall T. Decreasing Clostridium difficile infections in surgery: impact of a practice bundle incorporating a resident rounding protocol. Conn Med 2013;77:69-75.
50. Brakovich B, Bonham E, van Brackle L. War on the spore: Clostridium difficile disease among patients in a long-term acute care hospital. J Healthc Qual 2013;35:15-21.
51. Dubberke E, Carling P, Carrico R, et al. Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014;35:628-645.
52. Yakob L, Riley TV, Paterson DL, Marquess J, Clements AC. Assessing control bundles for Clostridium difficile: a review and mathematical model. Emerg Microbes Infect 2014;3:e43.
53. Koll BS, Ruiz R, Calfee DP, et al. Prevention of hospital-onset Clostridium difficile infection in the New York Metropolitan Region using a collaborative intervention model. J Health Qual 2014;36:35-45.
54. Kamboj M, Sheahan A, Sun J, et al. Transmission of Clostridium difficile during hospitalization for allogeneic stem cell transplant. Infect Control Hosp Epidemiol 2016;37:8-15.
55. Roth VR. The more we learn, the less we know. Infect Control Hosp Epidemiol 2016;37:16-18.
56. Gerding D, Johnson S, Peterson L, Mulligan M, Silva J. Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995;16:459-477.
57. Larson EL and 1992, 1993, and 1994 APIC Guidelines Committee. APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control 1995;23:251-269.
58. WHO guidelines on hand hygiene in health care: first global patient safety challenge, clean care is safer care. World Health Organization website. http://www.who.int/gpsc/5may/tools/9789241597906/en/. Published 2009. Accessed March 12, 2016.
59. Cohen SH, Gerding D, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infections Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-455.
60. Jabbar U, Leischner J, Kasper D, et al. Effectiveness of alcoholbased hand rubs for removal of Clostridium difficile spores from hands. Infect Control Hosp Epidemiol 2010;31:565-570.
61. Gerding DN, Muto C, Owens RC. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008;46: S43-S49.